Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. (åbner nyt vindue)

CRASH-3 Trial Collaborators

Kilde‎: Lancet 2019;394(10210):1713-23.

Indekseret‎: PubMed 31623894

DOI‎: 10.1016/S0140-6736(19)32233-0

https://www.ncbi.nlm.nih.gov/pubmed/31623894 (åbner nyt vindue)

Alternatives to allogeneic platelet transfusion. (åbner nyt vindue)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kilde‎: Br J Haematol 2016;175(3):381-92.

Indekseret‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (åbner nyt vindue)

Tranexamic acid: less bleeding and less thrombosis? (åbner nyt vindue)

Godier A, Roberts I, Hunt BJ.

Kilde‎: Crit Care 2012;16(3):135.

Indekseret‎: PubMed 22748073

DOI‎: 10.1186/cc11374

https://www.ncbi.nlm.nih.gov/pubmed/22748073 (åbner nyt vindue)

Tranexamic acid for reducing mortality in emergency and urgent surgery. (åbner nyt vindue)

Perel P, Ker K, Morales Uribe CH, Roberts I

Kilde‎: Cochrane Database Syst Rev 2013;(1):CD010245.

Indekseret‎: PubMed 23440847

DOI‎: 10.1002/14651858.CD010245.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23440847 (åbner nyt vindue)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (åbner nyt vindue)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Kilde‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

Indekseret‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (åbner nyt vindue)

Antifibrinolytic drugs for acute traumatic injury. (åbner nyt vindue)

Roberts I, Shakur H, Ker K, Coats T; CRASH‐2 Trial collaborators.

Kilde‎: Cochrane Database Syst Rev 2011;(1):CD004896.

Indekseret‎: PubMed 21249666

DOI‎: 10.1002/14651858.CD004896.pub3

https://www.ncbi.nlm.nih.gov/pubmed/21249666 (åbner nyt vindue)

Use of tranexamic acid to reduce bleeding in burns surgery. (åbner nyt vindue)

Tang YM, Chapman TW, Brooks P

Kilde‎: J Plast Reconstr Aesthet Surg 2012;65(5):684-6.

Indekseret‎: PubMed 21983540

DOI‎: 10.1016/j.bjps.2011.09.028

https://www.ncbi.nlm.nih.gov/pubmed/21983540 (åbner nyt vindue)

Tranexamic acid reduced blood transfusions in acute burn surgery: a retrospective case-controlled trial. (åbner nyt vindue)

Tapking C, Hundeshagen G, Kirchner M, Fischer S, Kneser U, Bliesener B

Kilde‎: Burns. 2022;48(3):522-28.

Indekseret‎: PubMed 35339324

DOI‎: 10.1016/j.burns.2022.03.002

https://pubmed.ncbi.nlm.nih.gov/35339324/ (åbner nyt vindue)

Salvage use of activated recombinant factor VII in the management of refractory bleeding following cardiac surgery. (åbner nyt vindue)

Barua A, Rao VP, Ramesh B, Barua B, El-Shafei H.

Kilde‎: J Blood Med 2011;2:131-4.

Indekseret‎: PubMed 22287872

DOI‎: 10.2147/JBM.S21609

https://www.ncbi.nlm.nih.gov/pubmed/22287872 (åbner nyt vindue)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (åbner nyt vindue)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Kilde‎: Transfusion 2009;49 Suppl 5:240S-7S.

Indekseret‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (åbner nyt vindue)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (åbner nyt vindue)

Fries D

Kilde‎: Transfusion 2013;53 Suppl 1:91S-5S.

Indekseret‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (åbner nyt vindue)

A Jehovah's Witness with complex abdominal trauma and coagulopathy: use of factor VII and a review of the literature. (åbner nyt vindue)

Haan J, Scalea T

Kilde‎: Am Surg 2005;71(5):414-5.

Indekseret‎: PubMed 15986972

https://www.ncbi.nlm.nih.gov/pubmed/15986972 (åbner nyt vindue)

Results of the control trial: efficacy and safety of recombinant activated factor VII in the management of refractory traumatic hemorrhage. (åbner nyt vindue)

Hauser CJ, Boffard K, Dutton R, Bernard GR, Croce MA, Holcomb JB, Leppaniemi A, Parr M, Vincent JL, Tortella BJ, Dimsits J, Bouillon B; CONTROL Study Group.

Kilde‎: J Trauma 2010;69(3):489-500.

Indekseret‎: PubMed 20838118

DOI‎: 10.1097/TA.0b013e3181edf36e

https://www.ncbi.nlm.nih.gov/pubmed/20838118 (åbner nyt vindue)

Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials. (åbner nyt vindue)

Hsia CC, Chin-Yee IH, McAlister VC.

Kilde‎: Ann Surg 2008;248(1):61-8.

Indekseret‎: PubMed 18580208

DOI‎: 10.1097/SLA.0b013e318176c4ec

https://www.ncbi.nlm.nih.gov/pubmed/18580208 (åbner nyt vindue)

Rescue treatment with recombinant factor VIIa is effective in patients with life-threatening bleedings secondary to major wound excision: a report of four cases. (åbner nyt vindue)

Johansson PI, Eriksen K, Alsbjørn B

Kilde‎: J Trauma 2006;61(4):1016-8.

Indekseret‎: PubMed 17033583

DOI‎: 10.1097/01.ta.0000239261.48022.f1

https://www.ncbi.nlm.nih.gov/pubmed/17033583 (åbner nyt vindue)

Use of recombinant activated factor VII in Jehovah's Witness patients with critical bleeding. (åbner nyt vindue)

Kandane-Rathnayake RK, Isbister JP, Zatta AJ, Aoki NJ, Cameron P, Phillips LE; Australian and New Zealand Haemostasis Registry Steering Committee

Kilde‎: ANZ J Surg 2013;83(3):155-60.

Indekseret‎: PubMed 23035873

DOI‎: 10.1111/j.1445-2197.2012.06285.x

https://www.ncbi.nlm.nih.gov/pubmed/23035873 (åbner nyt vindue)

Recombinant factor VIIa in trauma patients with the 'triad of death.' (åbner nyt vindue)

Mitra B, Cameron PA, Parr MJ, Phillips L.

Kilde‎: Injury 2012;43(9):1409-14.

Indekseret‎: PubMed 21345431

DOI‎: 10.1016/j.injury.2011.01.033

https://www.ncbi.nlm.nih.gov/pubmed/21345431 (åbner nyt vindue)

Low-dose recombinant factor VIIa for trauma patients with coagulopathy. (åbner nyt vindue)

Stein DM, Dutton RP, Hess JR, Scalea TM.

Kilde‎: Injury 2008;39(9):1054-61.

Indekseret‎: PubMed 18656871

DOI‎: 10.1016/j.injury.2008.03.032

https://www.ncbi.nlm.nih.gov/pubmed/18656871 (åbner nyt vindue)

Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (Novoseven®). (åbner nyt vindue)

Tanaka KA, Waly AA, Cooper WA, Levy JH.

Kilde‎: Anesthesiology 2003;98(6):1513-5.

Indekseret‎: PubMed 12766668

https://www.ncbi.nlm.nih.gov/pubmed/12766668 (åbner nyt vindue)

Alternatives to allogeneic platelet transfusion. (åbner nyt vindue)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kilde‎: Br J Haematol 2016;175(3):381-92.

Indekseret‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (åbner nyt vindue)

The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding. (åbner nyt vindue)

Fries D

Kilde‎: Transfusion 2013;53 Suppl 1:91S-5S.

Indekseret‎: PubMed 23301979

DOI‎: 10.1111/trf.12041

https://www.ncbi.nlm.nih.gov/pubmed/23301979 (åbner nyt vindue)

Plasma fibrinogen level on admission to the intensive care unit is a powerful predictor of postoperative bleeding after cardiac surgery with cardiopulmonary bypass. (åbner nyt vindue)

Kindo M, Hoang Minh T, Gerelli S, Perrier S, Meyer N, Schaeffer M, Bentz J, Announe T, Mommerot A, Collange O, Pottecher J, Cristinar M, Thiranos JC, Gros H, Mertes PM, Billaud P, Mazzucotelli JP

Kilde‎: Thromb Res 2014;134(2):360-8.

Indekseret‎: PubMed 24857189

DOI‎: 10.1016/j.thromres.2014.05.008

https://www.ncbi.nlm.nih.gov/pubmed/24857189 (åbner nyt vindue)

Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts. (åbner nyt vindue)

Larsen OH, Stentoft J, Radia D, Ingerslev J, Sørensen B

Kilde‎: Br J Haematol 2013;160(2):228-36.

Indekseret‎: PubMed 23151086

DOI‎: 10.1111/bjh.12118

https://www.ncbi.nlm.nih.gov/pubmed/23151086 (åbner nyt vindue)

Strategies to reduce the use of blood products: a European perspective. (åbner nyt vindue)

Theusinger OM, Felix C, Spahn DR.

Kilde‎: Curr Opin Anaesthesiol 2012;25(1):59-65.

Indekseret‎: PubMed 22113184

DOI‎: 10.1097/ACO.0b013e32834dec98

https://www.ncbi.nlm.nih.gov/pubmed/22113184 (åbner nyt vindue)

Desmopressin reduces transfusion needs after surgery: a meta-analysis of randomized clinical trials. (åbner nyt vindue)

Crescenzi G, Landoni G, Biondi-Zoccai G, Pappalardo F, Nuzzi M, Bignami E, Fochi O, Maj G, Calabrò MG, Ranucci M, Zangrillo A

Kilde‎: Anesthesiology 2008;109(6):1063-76.

Indekseret‎: PubMed 19034103

DOI‎: 10.1097/ALN.0b013e31818db18b

https://www.ncbi.nlm.nih.gov/pubmed/19034103 (åbner nyt vindue)

Alternatives to allogeneic platelet transfusion. (åbner nyt vindue)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kilde‎: Br J Haematol 2016;175(3):381-92.

Indekseret‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (åbner nyt vindue)

Desmopressin in treatment of haematological disorders and in prevention of surgical bleeding. (åbner nyt vindue)

Svensson PJ, Bergqvist PB, Juul KV, Berntorp E

Kilde‎: Blood Rev 2014;28(3):95-102.

Indekseret‎: PubMed 24703870

DOI‎: 10.1016/j.blre.2014.03.001

https://www.ncbi.nlm.nih.gov/pubmed/24703870 (åbner nyt vindue)

Coagulopathy caused by vitamin K deficiency in critically ill, hospitalized patients. (åbner nyt vindue)

Alperin JB

Kilde‎: JAMA 1987;258(14):1916-9.

Indekseret‎: PubMed 3656602

DOI‎: 10.1001/jama.1987.03400140078028

https://www.ncbi.nlm.nih.gov/pubmed/3656602 (åbner nyt vindue)

Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. (åbner nyt vindue)

Crowther MA, McDonald E, Johnston M, Cook D

Kilde‎: Blood Coagul Fibrinolysis 2002;13(1):49-52.

Indekseret‎: PubMed 11994567

DOI‎: 10.1097/00001721-200201000-00007

https://www.ncbi.nlm.nih.gov/pubmed/11994567 (åbner nyt vindue)

The use of fibrin sealant in burn operations. (åbner nyt vindue)

Foster K

Kilde‎: Surgery 2007;142(4 Suppl):S50-4.

Indekseret‎: PubMed 18019939

DOI‎: 10.1016/j.surg.2007.06.026

https://www.ncbi.nlm.nih.gov/pubmed/18019939 (åbner nyt vindue)

Use of fibrin sealant in thermal injury. (åbner nyt vindue)

McGill V, Kowal-Vern A, Lee M, Greenhalgh D, Gomperts E, Bray G, Gamelli R

Kilde‎: J Burn Care Rehabil 1997;18(5):429-34.

Indekseret‎: PubMed 9313125

DOI‎: 10.1097/00004630-199709000-00011

https://www.ncbi.nlm.nih.gov/pubmed/9313125 (åbner nyt vindue)

Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements. (åbner nyt vindue)

Schaden E, Kimberger O, Kraincuk P, Baron DM, Metnitz PG, Kozek-Langenecker S

Kilde‎: Br J Anaesth 2012;109(3):376-81.

Indekseret‎: PubMed 22719014

DOI‎: 10.1093/bja/aes186

https://www.ncbi.nlm.nih.gov/pubmed/22719014 (åbner nyt vindue)

Transfusion in trauma: why and how should we change our current practice? (åbner nyt vindue)

Theusinger OM, Spahn DR, Ganter MT.

Kilde‎: Curr Opin Anaesthesiol 2009;22(2):305-12.

Indekseret‎: PubMed 19390257

DOI‎: 10.1097/ACO.0b013e3283212c7c

https://www.ncbi.nlm.nih.gov/pubmed/19390257 (åbner nyt vindue)

Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis. (åbner nyt vindue)

Whiting P, Al M, Westwood M, Ramos IC, Ryder S, Armstrong N, Misso K, Ross J, Severens J, Kleijnen J

Kilde‎: Health Technol Assess 2015;19(58):1-228.

Indekseret‎: PubMed 26215747

DOI‎: 10.3310/hta19580

https://www.ncbi.nlm.nih.gov/pubmed/26215747 (åbner nyt vindue)